Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument

Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument Am J Cardiovasc Drugs (2016) 16:439–451 DOI 10.1007/s40256-016-0183-2 ORIGINAL RESEARCH ARTICLE Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument 1 2,3 3 1 1 • • • • Xiaowei Zhang Kun Zhao Zhenggang Bai Jing Yu Feng Bai Published online: 31 August 2016 Springer International Publishing Switzerland 2016 Abstract recommended (51 %), and not recommended (5 %). The Introduction Hypertension is an important public health scores for all domains (mean ± standard deviations) were challenge. The purpose of clinical practice guidelines ‘‘scope and purpose’’ (58.65 ± 12.67 %), ‘‘stakeholder (CPGs) is to provide explicit recommendations for clinical involvement’’ (48.07 ± 11.41 %), ‘‘rigor of development’’ practice, reduce inadequate variations, optimize results, (27.31 ± 12.29 %), ‘‘clarity of presentation’’ (53.89 minimize risks, and promote cost-effective practice. ± 11.09 %), ‘‘applicability’’ (40.10 ± 13.33 %), and Therefore, a highly methodological quality development ‘‘editorial independence’’ (38.75 ± 16.43 %). All differ- process for CPGs is more likely to yield a CPG that con- ences were statistically insignificant for all domains tains relevant and appropriate recommendations. (P [ 0.05) according to publication time. CPGs using an Method To assess the quality of CPGs for the prevention evidence-based (EB) http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument

Download PDF
13 pages

Loading next page...
 
/lp/springer-journals/clinical-practice-guidelines-for-hypertension-evaluation-of-quality-W6gYyXTsth

References (77)

Publisher
Springer Journals
Copyright
Copyright © 2016 by Springer International Publishing Switzerland
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.1007/s40256-016-0183-2
pmid
27580999
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs (2016) 16:439–451 DOI 10.1007/s40256-016-0183-2 ORIGINAL RESEARCH ARTICLE Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument 1 2,3 3 1 1 • • • • Xiaowei Zhang Kun Zhao Zhenggang Bai Jing Yu Feng Bai Published online: 31 August 2016 Springer International Publishing Switzerland 2016 Abstract recommended (51 %), and not recommended (5 %). The Introduction Hypertension is an important public health scores for all domains (mean ± standard deviations) were challenge. The purpose of clinical practice guidelines ‘‘scope and purpose’’ (58.65 ± 12.67 %), ‘‘stakeholder (CPGs) is to provide explicit recommendations for clinical involvement’’ (48.07 ± 11.41 %), ‘‘rigor of development’’ practice, reduce inadequate variations, optimize results, (27.31 ± 12.29 %), ‘‘clarity of presentation’’ (53.89 minimize risks, and promote cost-effective practice. ± 11.09 %), ‘‘applicability’’ (40.10 ± 13.33 %), and Therefore, a highly methodological quality development ‘‘editorial independence’’ (38.75 ± 16.43 %). All differ- process for CPGs is more likely to yield a CPG that con- ences were statistically insignificant for all domains tains relevant and appropriate recommendations. (P [ 0.05) according to publication time. CPGs using an Method To assess the quality of CPGs for the prevention evidence-based (EB)

Journal

American Journal of Cardiovascular Drugs – Springer Journals

Published: Aug 31, 2016

There are no references for this article.